Ferring Pharmaceuticals acquires global rights to MILPROSA (progesterone vaginal ring)
Saint Prex, Switzerland – September 28, 2015 – Ferring Pharmaceuticals announced today that it has acquired the global rights to…
-
-
Ferring Pharmaceuticals moves forward with early stage development of bacteriophage therapy for inflammatory bowel disease
Saint-Prex, Switzerland, 13 July 2015 – Ferring Pharmaceuticals announced today that it will collaborate with Baltimore-based Intralytix, Inc. in the…
-
Ferring Pharmaceuticals Launches 2015 Heart to Heart Video Contest Supporting Families Who’ve Overcome Infertility
Parents Encouraged to Share Triumph over Infertility for Chance to Win Educational Grants PARSIPPANY, N.J., April 20, 2015 /PRNewswire-USNewswire/ — Ferring…
-
Ferring Pharmaceuticals Receives FDA Approval for Growth Hormone Name Change, Acquires ZOMACTON™ [somatropin (rDNA origin)] for Injection and Needle-Free Device in the U.S.
Ferring Enters U.S. Pediatric Endocrinology Market with Acquisition from Teva Pharmaceutical Industries Ltd. PARSIPPANY, N.J., March 31, 2015 – Ferring…
-
Ferring Pharmaceuticals moves to strengthen growth with appointment of Chief Medical and Chief Scientific officers
Saint-Prex, Switzerland, 27 January 2015 – Ferring Pharmaceuticals announced today the appointment of Pascal Danglas, MD as Executive Vice President…